secwatch.observer — SEC 8-K summary
======================================

Issuer:     Healthtech Solutions, Inc./UT (—)
CIK:        0001307624
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001829126-25-004487
Event type: m_and_a
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Healthtech sells patents ($5M) and World Reach units ($25M); CEO replaced
-------------------------------------------------------------------------

- Sold one patent and four applications to Papyrus Therapeutic for $5M cash; perpetual license back to HTWC for wound care products.
- Sold 100% of World Reach Holdings to Papyrus Distribution for $25M base price, with $10M deferred via promissory notes.
- CEO and director Jelena Olmstead resigned effective June 6, 2025; James Pesoli appointed CEO.
- Transactions involved related parties (Pesoli and Olmstead had conflicting interests; approved by uninterested directors).
- Patent license grants HTWC perpetual, worldwide, non-exclusive right to manufacture DermaBind products with monthly royalties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1307624/000182912625004487/0001829126-25-004487-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1307624/000182912625004487/healthtech_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-004487

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer